Sign Out
MDI: Is indicated for the treatment in the regular treatment of reversible obstructive airways disease (ROAD), including asthma in children and adults, where use of a combination (bronchodilator and inhaled corticosteroid) is appropriate. This may include: Patients on effective maintenance doses of long acting β-agonist and inhaled corticosteroids; Patients who are asymptomatic on current inhaled corticosteroid therapy; Patients on regular bronchodilator therapy who require inhaled corticosteroid.
Also for the maintenance treatment of chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema.
DPI: For the maintenance and treatment of mild, moderate and severe persistent asthma in patient more than 5 years of age and in patients with chronic obstructive pulmonary disease.
